Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Physicians Believe Pharma Websites Are Not Credible Sources of Information

By PR Newswire | May 16, 2017

Poor pharma digital marketing damages credibility with physicians, Manhattan Research study finds.

Physicians value useful content from pharma that helps them do their jobs and manage care better, such as quality scientific information, patient education and diagnosis tools. However, physicians say that most of what they get from drug companies online is just advertising and they feel few pharmas are doing a good job at providing quality digital content, according to the Manhattan Research Taking the Pulse® U.S. 2017 study. As a result, just 27% of physicians say they find pharma websites to be a credible source of professional information.

The findings are based on a survey of 2,784 U.S. physicians across 25+ specialties, exploring their use of emerging technology, how they find information and make decisions, and what they want from pharma companies.

Key physician findings from the Taking the Pulse® U.S. 2017 study:

  • Poor-quality digital scientific content: Quality scientific content is essential to earning physician trust – 70% of U.S. physicians agree “it is crucial that pharma companies provide education resources rooted in science to gain my trust.” However, half of all U.S. physicians say that no pharma company is providing quality scientific content online.
  • Physicians feeling ad overload: 62% of physicians agree that the info pharma companies provide on third-party websites for healthcare professionals “are always ads” for their products, and only one in three (34%) trust the information pharmas provide on these websites. Physicians want more from pharma on these websites – for example, 54% of cardiologists want pharma-sponsored continuing medical education on non-pharma websites for providers, and 46% of urologists want disease diagnosis tools.
  • Lackluster videos: 49% of physicians who watch professional online video agree it influences their clinical decisions, yet 52% of physicians don’t think that any pharma company is doing a good job at providing quality physician video content.
  • Mobile missteps: 86% of physicians use a smartphone to access digital resources for professional purposes, but 41% of smartphone users don’t visit pharma websites more often because it takes too long to find the information they need.

Comments from Decision Resources Group analysts:

  • “Pharmas are doing a better job of providing a variety of digital content to physicians than they have in the past,” said Kelly Pinola, Senior Analyst, Physician Research. “However, physicians are telling us that pharma brands continue to disappoint when it comes to delivering the basic information they need to support their practices. Pharma needs to dial down the promotional messaging and lead with valuable educational resources in order to regain physician trust. The good news for pharmas is that there’s an opportunity here for them to differentiate themselves as truly user-centered organizations.”
  • “What this study tells us is that pharma marketers need to stop chasing tech trends and refocus on what their customers really need to make better medical decisions and improve patient care,” said Pinola. “Somewhere on the road to digital innovation, pharma lost sight of its core mission to serve physicians as partners in care. Instead of implementing new technologies just for the sake of it, pharma marketers should think about the needs of their customers and deliver solutions that address those needs.”

(Source: PR Newswire)

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!

Related Articles Read More >

From automation islands to connected plants: A roadmap for pharma manufacturers
This is the logo of Johnson & Johnson.
Johnson & Johnson announces new North Carolina pharma plant
Myths about conveyors and measures to make data-driven purchasing decisions
The blueprint for personalized biopharma
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE